Radiographic studies of the effect of benoxaprofen on bone damage in the adjuvant arthritic rat.
The ability of benoxaprofen to suppress bone damage associated with adjuvant-induced arthritis in rats was studied radiographically over a 49-day period. Benoxaprofen was administered orally at a daily dose of 30 mg/kg. Treated and control groups of rats were examined at seven-day intervals from 14 through 49 days. Benoxaprofen showed significant suppression of bone damage at all time intervals. Benoxaprofen was compared in a radiographic bone study with other nonsteroidal anti-inflammatory agents. Benoxaprofen at doses of 10-40 mg/kg/day orally, administered from days 15 to 39 of the disease, was more effective in suppressing bone damage exhibiting toxic effects than other agents. This modification of the experimental disease process by benoxaprofen may be due in part to its reported ability to suppress monocyte migration into inflammatory sites.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy*; D001169:Arthritis, Experimental / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D001175:Arthrography; D001847:Bone Diseases / Q000000981:diagnostic imaging* / Q000209:etiology; D005528:Foot / Q000000981:diagnostic imaging; D008297:Male; D011422:Propionates / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D011422:Propionates; C011677:benoxaprofen